AAAAAA

   
Results: 1-8 |
Results: 8
beta-catenin expression is altered in human colonic aberrant crypt foci
Authors: Hao, XP Pretlow, TG Rao, JS Pretlow, TP
Citation: Xp. Hao et al., beta-catenin expression is altered in human colonic aberrant crypt foci, CANCER RES, 61(22), 2001, pp. 8085-8088
Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60 : 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61 : 1874-1878, 2001.
Authors: Pretlow, TP Bird, RP
Citation: Tp. Pretlow et Rp. Bird, Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60 : 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61 : 1874-1878, 2001., CANCER RES, 61(20), 2001, pp. 7699-7700
Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients
Authors: Hao, XP Pretlow, TG Rao, JS Pretlow, TP
Citation: Xp. Hao et al., Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients, CANCER RES, 61(2), 2001, pp. 419-422
Prostate cancer and other xenografts from cells in peripheral blood of patients
Authors: Pretlow, TG Schwartz, S Giaconia, JM Wright, AL Grimm, HA Edgehouse, NL Murphy, JR Markowitz, SD Jamison, JM Summers, JL Hamlin, CR MacLennan, GT Resnick, MI Pretlow, TP Connell, CF
Citation: Tg. Pretlow et al., Prostate cancer and other xenografts from cells in peripheral blood of patients, CANCER RES, 60(15), 2000, pp. 4033-4036
Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions
Authors: Hao, XP Willis, JE Pretlow, TG Rao, JS MacLennan, GT Talbot, IC Pretlow, TP
Citation: Xp. Hao et al., Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions, CANCER RES, 60(1), 2000, pp. 18-21
A new human prostate carcinoma cell line, 22R upsilon 1
Authors: Sramkoski, RM Pretlow, TG Giaconia, JM Pretlow, TP Schwartz, S Sy, MS Marengo, SR Rhim, JS Zhang, DS Jacobberger, JW
Citation: Rm. Sramkoski et al., A new human prostate carcinoma cell line, 22R upsilon 1, IN VITRO-AN, 35(7), 1999, pp. 403-409
Molecular cytogenetic studies of a serially transplanted primary prostaticcarcinoma xenograft (CWR22) and four relapsed tumors
Authors: Kochera, M Depinet, TW Pretlow, TP Giaconia, JM Edgehouse, NL Pretlow, TG Schwartz, S
Citation: M. Kochera et al., Molecular cytogenetic studies of a serially transplanted primary prostaticcarcinoma xenograft (CWR22) and four relapsed tumors, PROSTATE, 41(1), 1999, pp. 7-11
The identification of monoclonality in human aberrant crypt foci
Authors: Siu, IM Robinson, DR Schwartz, S Kung, HJ Pretlow, TG Petersen, RB Pretlow, TP
Citation: Im. Siu et al., The identification of monoclonality in human aberrant crypt foci, CANCER RES, 59(1), 1999, pp. 63-66
Risultati: 1-8 |